Skip to main content
. Author manuscript; available in PMC: 2015 Apr 28.
Published in final edited form as: Am J Transplant. 2011 Jun 14;11(9):1868–1876. doi: 10.1111/j.1600-6143.2011.03593.x

Table 2.

Anti-HLA donor-specific antibodies

Chronic rejection (N=39) Comparator (N=39) p-Value
Any DSA ever 92% 61% p = 0.003
Preformed 60%* 41% NS
De novo 62%** 38% p =0.047
De novo <1 year 44%** 13% p =0.004
DSA post-OLT 79%** 56% p =0.047
Any DSA ever
 Class I 10% 5% p =0.008
 Class II 38% 33%
 Class I and II 44% 23%
 None 8% 39%

Number of patients analyzed was 39 except

*

N = 35,

**

N = 34.

OLT, orthotopic liver transplant.